Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial–mesenchymal transition

References

• Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):1–10. doi:10.1038/ki.2011.379.
   Web of Science ®Google Scholar
• Tampe B, Steinle U, Tampe D, et al. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression. Kidney Int. 2017;91(1):157–176. doi:10.1016/j.kint.2016.07.042.
   PubMed Web of Science ®Google Scholar
• Arai S, Kitada K, Yamazaki T, et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. 2016;22(2):183–193. doi:10.1038/nm.4012.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang W. Role of fatty acid oxidation in the pathogenesis and prognosis of acute kidney injury induced by ischemia reperfusion. Chinese J Nephrol. 2019;35(10):784–789.
   Google Scholar
• Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568–579. doi:10.1016/j.kint.2017.09.033.
   PubMed Web of Science ®Google Scholar
• Venkatachalam MA, Weinberg JM, Kriz W, et al. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26(8):1765–1776. doi:10.1681/ASN.2015010006.
   PubMed Web of Science ®Google Scholar
• Iwakura T, Zhao Z, Marschner JA, et al. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration. Nephrol Dial Transplant. 2019;34(10):1669–1680. doi:10.1093/ndt/gfy397.
   PubMed Web of Science ®Google Scholar
• Li M, Li C-M, Ye Z-C, et al. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice. J Cell Mol Med. 2020;24(9):5109–5121. doi:10.1111/jcmm.15148.
   PubMed Web of Science ®Google Scholar
• Shen Y, Jiang L, Wen P, et al. Tubule-derived lactate is required for fibroblast activation in acute kidney injury. Am J Physiol Renal Physiol. 2020;318(3):F689–F701. doi:10.1152/ajprenal.00229.2019.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, André-Grégoire G, Nguyen Dinh Cat A, et al. Benefit of mineralocorticoid receptor antagonism in AKI: role of vascular smooth muscle Rac1. J Am Soc Nephrol. 2017;28(4):1216–1226. doi:10.1681/ASN.2016040477.
   PubMed Web of Science ®Google Scholar
• Zhao JY, Wang XL, Yang YC, et al. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition. Hum Exp Toxicol. 2020;39(12):1628–1638. doi:10.1177/0960327120937334.
   PubMed Web of Science ®Google Scholar
• Huang H, Li T, Ye G, et al. High expression of COL10A1 is associated with poor prognosis in colorectal cancer. Onco Targets Ther. 2018;11:1571–1581. doi:10.2147/OTT.S160196.
   PubMed Web of Science ®Google Scholar
• Li T, Huang H, Shi G, et al. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Cell Death Dis. 2018;9(9):849. doi:10.1038/s41419-018-0877-2.
   PubMedGoogle Scholar
• Zhou W, Chen YX, Ke B, et al. circPlekha7 suppresses renal fibrosis via targeting miR-493-3p/KLF4. Epigenomics. 2022;14(4):199–217. doi:10.2217/epi-2021-0370.
   PubMed Web of Science ®Google Scholar
• Zhao JY, Wu YB. Huaier extract attenuates acute kidney injury to chronic kidney disease transition by inhibiting endoplasmic reticulum stress and apoptosis via miR-1271 upregulation. Biomed Res Int. 2020;2020:9029868–9029868. doi:10.1155/2020/9029868.
   PubMed Web of Science ®Google Scholar
• Botros SR, Matouk AI, Anter A, et al. Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1/NF-κB signaling pathway. Environ Toxicol Pharmacol. 2022;94:103907. doi:10.1016/j.etap.2022.103907.
   PubMed Web of Science ®Google Scholar
• Zhou D, Tan RJ, Fu H, et al. Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword. Lab Invest. 2016;96(2):156–167. doi:10.1038/labinvest.2015.153.
   PubMed Web of Science ®Google Scholar
• Edeling M, Ragi G, Huang S, et al. Developmental signalling pathways in renal fibrosis: the roles of notch, wnt and hedgehog. Nat Rev Nephrol. 2016;12(7):426–439. doi:10.1038/nrneph.2016.54.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang X, Xu J, et al. AZD4547 attenuates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation: the role of FGFR1 in renal tubular epithelial cells. Drug Des Devel Ther. 2020;14:833–844. doi:10.2147/DDDT.S224343.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang L, Chen R, et al. SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy. Front Physiol. 2018;9:1526. doi:10.3389/fphys.2018.01526.
   PubMed Web of Science ®Google Scholar
• Pan G, Liu Y, Shang L, et al. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun. 2021;41(3):199–217. doi:10.1002/cac2.12138.
   PubMed Web of Science ®Google Scholar
• Feng J, Hu S, Liu K, et al. The role of MicroRNA in the regulation of tumor epithelial–mesenchymal transition. Cells. 2022;11(13):1981. doi:10.3390/cells11131981.
   PubMed Web of Science ®Google Scholar
• Uhan S, Hauptman N. Metastatic EMT phenotype is governed by microRNA-200-mediated competing endogenous RNA networks. Cells. 2021;11(1):73. doi:10.3390/cells11010073.
   PubMed Web of Science ®Google Scholar
• Srivastava SP, Hedayat AF, Kanasaki K, et al. microRNA crosstalk influences epithelial-to-mesenchymal, endothelial-to-mesenchymal, and macrophage-to-mesenchymal transitions in the kidney. Front Pharmacol. 2019;10:904. doi:10.3389/fphar.2019.00904.
   PubMed Web of Science ®Google Scholar
• Venkatesh J, Wasson M-CD, Brown JM, et al. LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack. Cancer Lett. 2021;509:81–88. doi:10.1016/j.canlet.2021.04.002.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yang H, Liu C, et al. Microneedle patch loaded with exosomes containing microRNA‐29b prevents cardiac fibrosis after myocardial infarction. Adv Healthc Mater. 2023;12(13):e2202959. doi:10.1002/adhm.202202959.
   PubMed Web of Science ®Google Scholar
• Yan L, Su Y, Hsia I, et al. Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment. Mol Ther Nucleic Acids. 2023;32:36–47. doi:10.1016/j.omtn.2023.02.031.
   PubMedGoogle Scholar
• Chang JW, Tsai HL, Chen CW, et al. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation. J Cell Mol Med. 2012;16(12):2935–2949. doi:10.1111/j.1582-4934.2012.01610.x.
   PubMed Web of Science ®Google Scholar
• Fan JM, Ng YY, Hill PA, et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 1999;56(4):1455–1467. doi:10.1046/j.1523-1755.1999.00656.x.
   PubMed Web of Science ®Google Scholar
• Li J, Gorski DJ, Anemaet W, et al. Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism. Arthritis Res Ther. 2012;14(3):R151. doi:10.1186/ar3887.
   PubMed Web of Science ®Google Scholar
• Castro NE, Kato M, Park JT, et al. Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling Cascade and microRNAs in renal mesangial cells. J Biol Chem. 2014;289(42):29001–29013. doi:10.1074/jbc.M114.600783.
   PubMed Web of Science ®Google Scholar
• Bertero A, Brown S, Madrigal P, et al. The SMAD2/3 interactome reveals that TGFβ controls m(6)a mRNA methylation in pluripotency. Nature. 2018;555(7695):256–259. doi:10.1038/nature25784.
   PubMed Web of Science ®Google Scholar
• Yang X, Li B, Guan Y, et al. Expressions and related mechanisms of miR-212 and KLF4 in rats with acute kidney injury. Mol Cell Biochem. 2021;476(4):1741–1749. doi:10.1007/s11010-020-04016-x.
   PubMed Web of Science ®Google Scholar
• Xu D, Chen P-P, Zheng P-Q, et al. KLF4 initiates sustained Yap activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury. Acta Pharmacol Sin. 2021;42(3):436–450. doi:10.1038/s41401-020-0463-x.
   PubMed Web of Science ®Google Scholar
• Rane MJ, Zhao Y, Cai L. Krϋppel-like factors (KLFs) in renal physiology and disease. EBioMedicine. 2019;40:743–750. doi:10.1016/j.ebiom.2019.01.021.
   PubMed Web of Science ®Google Scholar
• Wen Y, Lu X, Ren J, et al. KLF4 in macrophages attenuates TNFα-mediated kidney injury and fibrosis. J Am Soc Nephrol. 2019;30(10):1925–1938. doi:10.1681/ASN.2019020111.
   PubMed Web of Science ®Google Scholar